Open Access. Powered by Scholars. Published by Universities.®
Natural Products Chemistry and Pharmacognosy Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Academic -- UNF -- Doctor of Nursing Practice; Dissertations (1)
- Academic -- UNF -- Nursing; DNP; D.N.P.; cannabis; marijuana; chronic pain; neuropathic pain; Marijuana -- Therapeutic use -- Effectiveness -- Statistics; Cannabis -- Therapeutic use -- Effectiveness -- Statistics; Chronic pain -- Alternative treatment; Chronic pain -- Prevention (1)
- Antihypertensive (1)
- Antispasmodic (1)
- Bronchodilator (1)
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Natural Products Chemistry and Pharmacognosy
Antispasmodic, Bronchodilator And Blood Pressure Lowering Properties Of Hypericum Oblongifolium - Possible Mechanism Of Action, Arif-Ullah Khan, Munasib Khan, Fazal Subhan, Anwar Gilani
Antispasmodic, Bronchodilator And Blood Pressure Lowering Properties Of Hypericum Oblongifolium - Possible Mechanism Of Action, Arif-Ullah Khan, Munasib Khan, Fazal Subhan, Anwar Gilani
Anwar Gilani
The crude extract of Hypericum oblongifolium (Ho.Cr), which tested positive for flavonoids, saponins and tannins caused concentration-dependent (0.1-1.0 mg/mL) relaxation of spontaneous and high K(+) (80 mM)-induced contractions in isolated rabbit jejunum preparations, suggesting a Ca(++) antagonistic effect, which was confirmed when pretreatment of the tissue with Ho.Cr produced a rightward shift in the Ca(++) concentration-response curves, like that caused by verapamil. Ho.Cr relaxed carbachol (1 mu M) and high K(+)-induced contractions in guinea pig tracheal preparations. It caused a dose-dependent (3-100 mg/kg) fall in arterial blood pressure of rats under anesthesia. In isolated guinea pig atria, Ho.Cr caused inhibition …
Meta-Analysis Of Herbal Cannabis Therapy For Chronic Pain, Michael J. Seneca
Meta-Analysis Of Herbal Cannabis Therapy For Chronic Pain, Michael J. Seneca
UNF Graduate Theses and Dissertations
Since the first so-called “medical marijuana” legislation was passed in California in 1996, a total of twenty states and the District of Columbia have passed laws permitting limited use of cannabis. Despite the changes in state laws, cannabis remains illegal for any purpose under federal law. Changes in state laws have coincided with a renewed interest in the substance for the treatment of a variety of conditions. There has been a significant increase in published data over the past twenty years examining the efficacy of cannabis as an appetite stimulant, antiemetic agent, and analgesic adjuvant. The purpose of this meta-analysis …